Ascend Wellness Holdings (AAWH) Cash from Operations (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Cash from Operations of 19411000.0 for Q1 2026, down 426.84% year-over-year from 5939000.0 in Q1 2025, and down 218.97% quarter-over-quarter from 16316000.0 in Q4 2025.
Ascend Wellness Holdings (AAWH) Cash from Operations (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Cash from Operations history runs 7 years deep, the most recent figure standing at 19411000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 426.84% year-over-year to 19411000.0; the TTM figure through Mar 2026 stood at 12703000.0 (down 83.14% YoY), while the FY2025 annual figure was 38053000.0, down 48.08% from the prior year.
- Cash from Operations for Q1 2026 stood at 19411000.0, down from 16316000.0 in the prior quarter.
- The five-year high for Cash from Operations was 35166000.0 in Q4 2024, with the low at 19411000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 5778000.0 (2023), against an average of 7583058.82.
- The sharpest annual moves came in 2023 and 2026: Cash from Operations soared 1644.44% in 2023, then plunged 426.84% in 2026.
- Ascend Wellness Holdings' Cash from Operations stood at 16071000.0 in 2022, then surged by 203.71% to 16668000.0 in 2023, then soared by 110.98% to 35166000.0 in 2024, then plunged by 53.6% to 16316000.0 in 2025, then plunged by 218.97% to 19411000.0 in 2026.
- Business Quant data shows AAWH's Cash from Operations at 19411000.0 in Q1 2026, 16316000.0 in Q4 2025, and 2003000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ascend Wellness Holdings | 97.42 Mn | 30.42 Mn | 45.49 Mn | 22.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.45 Mn |
| Jun 30, 2026 | 22.45 Mn |
| Mar 31, 2026 | -19.41 Mn |
| Mar 31, 2026 | -19.41 Mn |
| Dec 31, 2025 | 16.32 Mn |
| Dec 31, 2025 | 16.32 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Jun 30, 2025 | 17.80 Mn |
| Jun 30, 2025 | 17.80 Mn |
| Mar 31, 2025 | 5.94 Mn |
| Mar 31, 2025 | 5.94 Mn |
| Dec 31, 2024 | 35.17 Mn |
| Dec 31, 2024 | 35.17 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | 32.25 Mn |
| Jun 30, 2024 | 32.25 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Mar 31, 2024 | 3.90 Mn |